BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19192709)

  • 1. Case study. Trust, translation and HAART. Commentary.
    Delancey DB
    Hastings Cent Rep; 2008; 38(6):14. PubMed ID: 19192709
    [No Abstract]   [Full Text] [Related]  

  • 2. Case study. Trust, translation and HAART. Commentary.
    Rentmeester CA
    Hastings Cent Rep; 2008; 38(6):13-4. PubMed ID: 19195099
    [No Abstract]   [Full Text] [Related]  

  • 3. Trust, translation, and HAART.
    Hastings Cent Rep; 2008; 38(6):13. PubMed ID: 19192708
    [No Abstract]   [Full Text] [Related]  

  • 4. Granulomatous cheilitis in an HIV positive patient on HAART therapy.
    Dalessandro M; Vecchiet J; Angelucci D; Pizzigallo E; Tulli A; Amerio P
    Eur J Dermatol; 2008; 18(5):591. PubMed ID: 18779107
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute promyelocytic leukemia in an HIV-infected patient: a case report.
    De Vita S; De Matteis S; Laurenti L; Sorà F; Tarnani M; Cingolani A; Sica S
    Am J Hematol; 2006 Apr; 81(4):300. PubMed ID: 16550512
    [No Abstract]   [Full Text] [Related]  

  • 6. [Highly active antiretroviral therapy in HIV sero-positive children. Disease progression by baseline clinical, immunological and virological status].
    Rodríguez de Schiavi MS; Scrigni A; García Arrigoni P; Bologna R; Barboni G; Redondo J; Nastri M; Mecikovsky D; Cantisano C; Moreno R; Siciliani D; Lencina M; Luedicke N; Rezzónico G; Torolla JL; López Papucci S; Luis M; Libonati C; Gamba L; Barbarysky J; Pérez Hernández E; Zlatkes R
    Arch Argent Pediatr; 2009 Jun; 107(3):212-20. PubMed ID: 19543629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
    Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C
    Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What works in coping with HIV? A meta-analysis with implications for coping with serious illness.
    Moskowitz JT; Hult JR; Bussolari C; Acree M
    Psychol Bull; 2009 Jan; 135(1):121-41. PubMed ID: 19210056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opening session: welcome from the Sinikithemba Choir.
    Tabethe Z
    Top HIV Med; 2003; 11(3):68-9. PubMed ID: 12837964
    [No Abstract]   [Full Text] [Related]  

  • 10. Making sure your care doesn't get lost in translation.
    Slomski AJ
    Med Econ; 1993 May; 70(10):122, 127, 131-2 passim. PubMed ID: 10126057
    [No Abstract]   [Full Text] [Related]  

  • 11. Elimination of HIV by test and treat: a phantom of wishful thinking?
    Kretzschmar ME; van der Loeff MF; Coutinho RA
    AIDS; 2012 Jan; 26(2):247-8. PubMed ID: 22179229
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The physical, emotional and interpersonal impact of HAART: exploring the realities of HIV seropositive individuals on combination therapy.
    Halkitis PN; Shrem MT; Zade DD; Wilton L
    J Health Psychol; 2005 May; 10(3):345-58. PubMed ID: 15857867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andractim for HAART-associated breast enlargement.
    TreatmentUpdate; 2001 Sep; 13(5):6. PubMed ID: 11768864
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mitochondrial toxicity: a case of palpebral ptosis in a woman infected by HIV and treated with HAART including zidovudine].
    Zannou DM; Azon-Kouanou A; Bashi BJ; Gougounon A; Zinsou R; Adé G; Houngbè F
    Bull Soc Pathol Exot; 2009 May; 102(2):97-8. PubMed ID: 19583030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART).
    Schindler K; Rieger A; Tura A; Gmeinhardt B; Touzeau-Römer V; Haider D; Pacini G; Ludvik B
    Horm Metab Res; 2009 Jul; 41(7):573-9. PubMed ID: 19322744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
    Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
    Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer in HIV-positive individuals: what we know and what we don't.
    Walters Z; Shamash J; Powles T
    J HIV Ther; 2007 Sep; 12(3):66-7. PubMed ID: 17962795
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-HIV agents. Should HAART begin right after an HIV diagnosis?
    TreatmentUpdate; 2009; 21(3):2-3. PubMed ID: 19630120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.